Prognostic and Predictive Models in Myelofibrosis

Current Hematologic Malignancy Reports, Год журнала: 2024, Номер 19(5), С. 223 - 235

Опубликована: Авг. 24, 2024

Myelofibrosis (MF) includes prefibrotic primary MF (pre-PMF), overt-PMF and secondary (SMF). Median overall survival (OS) of pre-PMF, SMF patients is around 14 years, seven nine respectively. Main causes mortality are non-clonal progression transformation into blast phase.

Язык: Английский

Neoplasias mieloproliferativas crónicas Filadelfia negativas

Medicine - Programa de Formación Médica Continuada Acreditado, Год журнала: 2024, Номер 14(20), С. 1157 - 1170

Опубликована: Ноя. 1, 2024